泣く子も黙る感染対策

出版社： 中外医学社
著者：
発行日： 2023-08-20
分野： 臨床医学：内科  >  感染症/AIDS
ISBN： 9784498021464
電子書籍版： 2023-08-20 （1版1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：4～8営業日

3,520 円(税込)

購入する
電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

3,520 円(税込)

購入する

商品紹介

2020年以降の新型コロナ対応の豊富な経験も踏まえ，聖路加国際病院感染対策室マネジャーである熟練の著者がエキスパートならではの視点から考察，詳述．現状を冷静に見つめ，具体例やエビデンスも豊かにICTが目指すべき理想とそこに向かう道筋を指し示し泣く子も黙る“鉄壁”を目指す．感染対策にかかわるすべての医療者が今読んでおきたい，具体的な指針が詰まった一冊！

目次

  • 【1】感染対策がうまくいく病院の5つの特徴
    　　特徴1　安全性を脅かしかねない些細な兆候を見逃さない
    　　特徴2　周囲の状況や過去の経験を単純化しない
    　　特徴3　期待されるパフォーマンスから日常業務が逸脱している状況に敏感である
    　　特徴4　エラーが起きても大事に至らない回復力（レジリエンスresilience）を大事にしている
    　　特徴5　年齢や序列にとらわれない専門家の重用

    【2】薬剤耐性（AMR）対策アクションプラン
    　　　―病院における薬剤耐性菌伝播防止のための基本戦略―
    　　基本戦略（1）　手指衛生
    　　基本戦略（2）　接触予防策の賢い使い方
    　　基本戦略（3）　サーベイランスなくして戦略なし
    　　基本戦略（4）　AMR対策における情報活用
    　　基本戦略（5）　感染対策の事前評価

    【3】針刺し・切創・粘膜／創傷汚染の予防と対応
    ［1］職業曝露の予防
    　　1　針刺し・切創・粘膜／創傷汚染とは何か
    　　2　職業曝露に伴う血液媒介病原体の感染リスク
    　　3　予防のためにできること
    ［2］職業曝露後対応
    　　1　職業曝露発生直後の対応
    　　2　B型肝炎ウイルスへの曝露後対応
    　　3　C型肝炎ウイルスへの曝露後対応
    　　4　ヒト免疫不全ウイルスへの曝露後対応
    　　5　ヒトT細胞白血病ウイルス1型への対応

    【4】医療関連感染予防のための水質管理
    　　1　レジオネラ対策
    　　2　加湿器の管理
    　　3　製氷機の管理
    　　4　生花の取り扱い
    　　5　ウォーターサーバーの使用

    【5】感染対策における管理図の活用
    　　1　管理図とは
    　　2　管理図のフォーマット
    　　3　管理図の種類
    　　4　X—R管理図の活用
    　　5　p管理図の活用
    　　6　u管理図の活用
    　　7　管理状態の確認と管理線の改訂

    【6】微生物検査室におけるバイオセーフティ
    　　1　検査室関連感染とは
    　　2　バイオハザードとバイオセーフティ
    　　3　リスク評価
    　　4　基本的な感染対策
    　　5　追加的な感染対策

    【7】医療施設の建築・改築・解体工事における感染対策
    　　1　工事に伴う医療関連感染リスク
    　　2　リスク評価と対策
    　　3　PCRAの運用例
    　　4　ICRA（infection control risk assessment）マトリックス

    【8】感染源になりうる病院環境
    　　1　高頻度接触環境表面
    　　2　シンク
    　　3　プライバシーカーテン
    　　4　床
    　　5　天井

    【9】清掃と医療関連感染
    　　1　清掃の質をどのように評価するか
    　　2　清潔さを追求する対策

    【10】超音波プローブの消毒
    　　1　医療器具のリスク分類と再生処理工程
    　　2　経腟・経直腸プローブに求められる消毒法
    　　3　経腟・経直腸プローブの医療関連感染リスク
    　　4　超音波検査用ゼリーを介した感染リスク
    　　5　今できることは何か

    【11】手指衛生
    ［1］基礎知識
    　　1　そもそも手指衛生は感染予防に有効なのか
    　　2　手洗いと手指消毒のどちらを優先すべきか
    　　3　手指衛生の手順の違いは効果に影響するか
    　　4　手指衛生は何秒間実施すればよいか
    　　5　ノンアルコール製剤は有用か
    　　6　アルコールは皮膚から吸収されるか
    ［2］手指衛生のタイミング
    　　　　手指衛生はいつ行うのがベストなのか
    ［3］手指衛生のモニタリング
    　　1　モニタリング法
    　　2　モニタリングデータの活用
    ［4］手指衛生について考える
    　　1　手指衛生を多面的に捉える
    　　2　リーダーシップ
    　　3　環境改善と体制整備
    　　4　教育と気づき
    　　5　患者の関与
    　　6　継続的モニタリング
    　　7　チャンピオンとロールモデル
    　　8　手指衛生は病院事業である

    【12】カテーテル関連尿路感染の予防
    　　領域1　必要な患者に限り使用する
    　　領域2　早期に抜去する
    　　領域3　清潔に挿入・管理する

    コラム　感染症業界ここがアカンやろ！
    　　　プロアクティブかつコスパ重視の中長期戦略がない！

    【13】医療現場におけるマスクの使い方
    　　1　サージカルマスク
    　　2　N95マスク
    　　3　電気ファン付き呼吸用保護具（PAPR）
    　　4　サージカルマスクか，N95マスクか

    【14】新興感染症のパンデミックにおける職業感染予防
    　　1　職業感染予防における医療機関と職員の責務，権利，役割
    　　2　実効性のある職業感染予防の体制
    　　3　制御のヒエラルキーに基づく職業感染予防の考え方

    【15】日常と非日常をつなぐ医療関連感染予防・制御の体制
    　　1　パンデミックがもたらす非日常のインパクト
    　　2　推奨される日常のIPC体制とは

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

1 感染対策がうまくいく病院の5つの特徴

P.6 掲載の参考文献
1) Chassin MR, Loeb JM. High reliability health care:getting there from here. Milbank Q. 2013;91:459-90.
PubMed
2) AHRQ. High reliability. Sep.7, 2019. https://psnet.ahrq.gov/primer/high-reliability
 
3) Shabot MM, Monroe D, Inurria J, et al. Memorial Hermann:high reliability from board to bedside. Jt Comm J Qual Patient Saf. 2013;39:253-7.
 

2 薬剤耐性 ( AMR ) 対策アクションプラン - 病院における薬剤耐性菌伝播防止のための基本戦略 -

P.12 掲載の参考文献
1) The review on antimicrobial resistance. Tackling drug-resistant infections globally:final report and recommendations. 2016. https://amr-review.org/sites/default/files/160518_Final%20paper_with%20cover.pdf
 
2) 厚生労働省. 薬剤耐性(AMR)対策について. 薬剤耐性(AMR)対策アクションプラン. http://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000120172.html
 
3) Health Research & Educational Trust. Hand Hygiene Project:Best Practices from Hospitals Participating in the Joint Commission Center for Transforming Healthcare Project. Chicago:Health Research & Educational Trust. 2010. http://www.hpoe.org/Reports-HPOE/hand_hygiene_project.pdf
 
4) Zingg W, Holmes A, Dettenkofer M, et al. Hospital organization, management, and structure for prevention of health-care-associated infection:a systematic review and expert consensus. Lancet Infect Dis. 2015;15:212-24.
PubMed
5) Whitby M, Pessoa-Silva CL, McLaws ML, et al. Behavioural considerations for hand hygiene practices:the basic building blocks. J Hosp Infect. 2007;65:1-8.
PubMed
6) Chassin MR, Mayer C, Nether K. Improving hand hygiene at eight hospitals in the United States by targeting specific causes of noncompliance. Jt Comm J Qual Patient Saf. 2015;41:4-12.
PubMed
7) Grint K. Leadership as person:putting the 'ship' back into 'leader-ship'. In:Leadership:Limits and Possibilities. London:Palgrave Macmillan;2005. p. 38.
 
8) World Health Organization. WHO guidelines on hand hygiene in health care:first global patient safety challenge:clean care is safer care. 2009. http://apps.who.int/iris/bitstream/10665/44102/1/9789241597906_eng.pdf
 
9) Centers for Disease Control and Prevention. Guideline for hand hygiene in health-care settings:recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. MMWR. 2002;51:1-44.
 
10) Reilly JS, Price L, Lang S, et al. A pragmatic randomized controlled trial of 6-step vs 3-step hand hygiene technique in acute hospital care in the United Kingdom. Infect Control Hosp Epidemiol. 2016;37:661-6.
 
11) WHO Hand Hygiene Technical Reference Manual:手指衛生テクニカルリファレンスマニュアル(日本語訳). https://amr.ncgm.go.jp/pdf/Hand-hygiene-technical-reference_Japanese.pdf
 
12) Reich JA, Goodstein ME, Callahan SE, et al. Physician report cards and rankings yield long-lasting hand hygiene compliance exceeding 90%. Crit Care. 2015;19:292.
 
13) World Health Organization. Evidence of hand hygiene to reduce transmission and infections by multidrug resistant organisms in health-care settings. 2009. http://www.who.int/gpsc/5may/MDRO_literature-review.pdf?ua=1
 
P.20 掲載の参考文献
1) Siegel JD, Rhinehart E, Jackson M, et al. Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in healthcare settings. 2006. https://www.cdc.gov/hicpac/pdf/MDRO/MDROGuideline2006.pdf
 
2) Siegel JD, Rhinehart E, Jackson M, et al. Healthcare Infection Control Practices Advisory Committee. Guideline for Isolation Precautions:Preventing Transmission of Infectious Agents in Healthcare Settings. 2007. http://www.cdc.gov/ncidod/dhqp/pdf/isolation2007.pdf
 
3) Society for Healthcare Epidemiology of America. Strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in acute care hospitals:2014 update. Infect Control Hosp Epidemiol. 2014;35:772-96.
PubMed
4) Coia JE, Duckworth GJ, Edwards DI, et al. Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J Hosp Infect. 2006;63 Suppl 1:S1-44.
 
5) Tacconelli E, Cataldo MA, Dancer SJ, et al. European Society of Clinical Microbiology. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect. 2014;20(Suppl 1):1-55.
 
6) Gandra S, Barysauskas CM, Mack DA, et al. Impact of contact precautions on falls, pressure ulcers and transmission of MRSA and VRE in hospitalized patients. J Hosp Infect. 2014;88:170-6.
PubMed
7) Edmond MB, Masroor N, Stevens MP, et al. The impact of discontinuing contact precautions for VRE and MRSA on device-associated infections. Infect Control Hosp Epidemiol. 2015;36:978-80.
PubMed
8) Almyroudis NG, Osawa R, Samonis G, et al. Discontinuation of systematic surveillance and contact precautions for vancomycin-resistant enterococcus (VRE) and its impact on the incidence of VRE faecium bacteremia in patients with hematologic malignancies. Infect Control Hosp Epidemiol. 2016;37:398-403.
PubMed
9) Martin EM, Russell D, Rubin Z, et al. Elimination of routine contact precautions for endemic methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus:a retrospective quasi-experimental study. Infect Control Hosp Epidemiol. 2016;37:1323-30.
PubMed
10) Lemieux C, Gardam M, Evans G, et al. Longitudinal multicenter analysis of outcomes after cessation of control measures for vancomycin-resistant enterococci. Infect Control Hosp Epidemiol. 2017;38:24-30.
PubMed
11) Widmer AF, Frei R, Erb S, et al. Transmissibility of Clostridium difficile without contact isolation:results from a prospective observational study with 451 patients. Clin Infect Dis. 2017;64:393-400.
PubMed
12) Derde LPG, Cooper BS, Goossens H, et al. Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units:an interrupted time series study and cluster randomised trial. Lancet Infect Dis. 2014;14:31-9.
PubMed
13) Zahar JR, Poirel L, Dupont C, et al. About the usefulness of contact precautions for carriers of extended-spectrum beta-lactamase-producing Escherichia coli. BMC Infect Dis. 2015;15:512.
PubMed
14) Khader K, Thomas A, Stevens V, et al. Association between contact precautions and transmission of methicillin-resistant Staphylococcus aureus in veterans affairs hospitals. JAMA Netw Open. 2021;4:e210971.
PubMed
15) Morgan DJ, Zhan M, Goto M, et al. The effectiveness of contact precautions on methicillin-resistant Staphylococcus aureus in long-term care across the United States. Clin Infect Dis. 2020;71:1676-83.
PubMed
16) Johnstone J, Shing E, Saedi A, et al. Discontinuing contact precautions for vancomycin-resistant enterococcus (VRE) is associated with rising VRE bloodstream infection rates in Ontario hospitals, 2009-2018:a quasi-experimental study. Clin Infect Dis. 2020;71:1756-9.
PubMed
17) Maechler F, Schwab F, Hansen S, et al. Contact isolation versus standard precautions to decrease acquisition of extended-spectrum β-lactamase-producing Enterobacterales in non-critical care wards:a cluster-randomised crossover trial. Lancet Infect Dis. 2020;20:575-84.
 
18) Slekovec C, Robert J, Berthelot P, et al. Do contact precautions reduce the incidence of intensive care unit-acquired Pseudomonas aeruginosa infections? The DPCPYO (detection and contact precautions for patients with P. aeruginosa) cluster-randomized crossover trial. Clin Infect Dis. 2021;73:e2781-8.
 
19) Marra AR, Edmond MB, Schweizer ML, et al. Discontinuing contact precautions for multidrug-resistant organisms:a systematic literature review and meta-analysis. Am J Infect Control. 2018;46:333-40.
PubMed
20) Kuenzli E, Jaeger VK, Frei R, et al. High colonization rates of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in Swiss travellers to South Asia-a prospective observational multicentre cohort study looking at epidemiology, microbiology and risk factors. BMC Infect Dis. 2014;14:528.
 
21) Overdevest I, Willemsen I, Rijnsburger M, et al. Extended-spectrum β-lactamase genes of Escherichia coli in chicken meat and humans, The Netherlands. Emerg Infect Dis. 2011;17:1216-22.
 
22) Leverstein-van Hall MA, Dierikx CM, Stuart JC, et al. Dutch patients, retail chicken meat and poultry share the same ESBL genes, plasmids and strains. Clin Microbiol Infect. 2011;17:873-80.
 
23) Geser N, Stephan R, Kuhnert P, et al. Fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in swine and cattle at slaughter in Switzerland. J Food Prot. 2011;74:446-9.
 
24) Tschudin-Sutter S, Lucet J-C, Mutters NT, et al. Contact precautions for preventing nosocomial transmission of extended-spectrum β lactamase-producing Escherichia coli:A point/counterpoint review. Clin Infect Dis. 2017;65:342-7.
 
25) Tomczyk S, Zanichelli V, Grayson ML, et al. Control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa in Healthcare Facilities:A systematic review and reanalysis of quasi-experimental studies. Clin Infect Dis. 2019;68:873-84.
PubMed
26) Banach DB, Bearman G, Barnden M, et al. Duration of contact precautions for acute-care Settings. Infect Control Hosp Epidemiol 2018;39:127-44.
PubMed
27) Kirkland KB. Taking off the gloves:toward a less dogmatic approach to the use of contact isolation. Clin Infect Dis. 2009;48:766-71.
 
P.26 掲載の参考文献
1) Organisation for Economic Co-operation and Development. OECD Reviews of Health Care Quality:Japan 2014 RAISING STANDARDS. Paris:OECD;2014.
 
2) Guidelines Working Group Centers for Disease Control and Prevention (CDC);German RR, Lee LM, Horan JM, et al. Updated guidelines for evaluating public health surveillance systems;recommendations from the guidelines working group. MMWR Recomm Rep. 2001;50:1-35.
 
3) The World Health Organization. Guidelines on core components of infection prevention and control programmes at the national and acute health care facility level. www.who.int/gpsc/ipc-components/en/
 
4) Krein SL, Greene MT, Apisarnthanarak A, et al. Infection prevention practices in Japan, Thailand, and the United States:results from national surveys. Clin Infect Dis. 2017;64:S105-11.
PubMed
5) Weiner LM, Webb AK, Limbago B, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections:summary of data reported to the national healthcare safety network at the Centers for Disease Control and Prevention, 2011-2014. Infect Control Hosp Epidemiol. 2016;37:1288-301.
 
6) El-Saed A, Balkhy HH, Weber DJ. Benchmarking local healthcare-associated infections:available benchmarks and interpretation challenges. J Infect Public Health. 2013;6:323-30.
PubMed
7) 日本環境感染学会JHAIS委員会. JHAIS医療器具関連感染サーベイランスマニュアル. http://www.kankyokansen.org/modules/iinkai/index.php?content_id=6
 
8) J-SIPHE感染対策連携共通プラットフォーム. 本事業について. https://j-siphe.ncgm.go.jp/Summary
 
P.37 掲載の参考文献
1) 国立感染症研究所細菌第二部, 鈴木里和, 松井真理, 他. 外来型カルバペネマーゼ産生腸内細菌科細菌の検出状況. IASR. 2014;35:287-8.
 
2) Gonzales R, Handley MA, Ackerman S, et al. Increasing the translation of evidence into practice, policy, and public health improvements:a framework for training health professionals in implementation and dissemination science. Acad Med. 2012;87:271-8.
 
3) Krein SL, Olmsted RN, Hofer TP, et al. Translating infection prevention evidence into practice using quantitative and qualitative research. Am J Infect Control. 2006;34:507-12.
PubMed
4) Blase K, Kiser L, Van Dyke M. The Hexagon Tool:Exploring Context. Chapel Hill:The National Implementation Research Network (NIRN). Frank Porter Graham Child Development Institute, University of North Carolina at Chapel Hill;2013.
 
5) Burke K, Morris K, McGarrigle L. An introductory guide to implementation:terms, concepts and frameworks. Centre for Effective Services. 2012.
 
6) The National Institute for Occupational Safety and Health (NIOSH). Hierarchy of controls. https://www.cdc.gov/niosh/topics/hierarchy/default.html
 
7) WHO. The world is running out of antibiotics, WHO report confirms. 20 September 2017. http://www.who.int/mediacentre/news/releases/2017/running-out-antibiotics/en/
 
P.47 掲載の参考文献
1) Metz A, Louison L. (2018) The Hexagon Tool:Exploring Context. Chapel Hill, NC:National Implementation Research Network, Frank Porter Graham Child Development Institute, University of North Carolina at Chapel Hill. Based on Kiser, Zabel, Zachik, & Smith (2007) and Blase, Kiser & Van Dyke (2013).
 
2) SHEA/IDSA/APIC Practice Recommendation. Strategies to prevent healthcare-associated infections through hand hygiene:2022 Update. Infect Control Hosp Epidemiol. 44:355-76.
PubMed
3) Armellino D, Hussain E, Schilling ME, et al. Using high-technology to enforce low-technology safety measures:the use of third-party remote video auditing and real-time feedback in healthcare. Clin Infect Dis. 2012;54:1-7.
PubMed
4) WHO Hand Hygiene Technical Reference Manual:手指衛生テクニカルリファレンスマニュアル(日本語訳). https://amr.ncgm.go.jp/pdf/Hand-hygiene-technical-reference_Japanese.pdf
 

3 針刺し・切創・粘膜 / 創傷汚染の予防と対応

P.59 掲載の参考文献
1) Occupational Safety and Health Administration. Bloodborne pathogens and needlestick prevention. Hazard recognition. https://www.osha.gov/SLTC/bloodbornepathogens/recognition.html
 
2) U. S. Public Health Service. Updated U. S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR Recomm Rep. 2001;50:1-52.
PubMed
3) 木戸内清. 医療災害. 感染症誌. 2002;76:851-6.
 
4) NHS Employers. Managing the risks of sharps injuries. 2015. http://www.nhsemployers.org/case-studies-and-resources/2015/12/hswpg-sharps-guidance
 
5) Centers for Disease Control and Prevention. CDC guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management. https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm
 
6) Kuhar DT, Henderson DK, Struble KA, et al;US Public Health Service Working Group. Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis. Infect Control Hosp Epidemiol. 2013;34:875-92.
 
7) Reddy VK, Lavoie MC, Verbeek JH, et al. Devices for preventing percutaneous exposure injuries caused by needles in healthcare personnel. Cochrane Database Syst Rev. 2017;11:CD009740.
PubMed
8) 李宗子. 医療機関における職業感染予防と曝露後の対処. 各種安全器材の導入状況と課題 針刺し・切創防止に向けて. 化療の領域. 2014;30:1381-9.
 
9) 職業感染制御研究会. 安全器材と個人用防護具. http://www.safety.jrgoicp.org/index.php?option=com_content&view=category&layout=blog&id=160&Itemid=541
 
10) National Institute for Occupational Safety and Health. NIOSH alert:preventing needlestick injuries in health care settings. https://www.cdc.gov/niosh/docs/2000-108/pdfs/2000-108.pdf
 
11) Jagger J, Berguer R, Phillips EK, et al. Increase in sharps injuries in surgical settings versus nonsurgical settings after passage of national needlestick legislation. J Am Coll Surg. 2010;210:496-502.
PubMed
12) Wada K, Yoshikawa T, Lee JJ, et al. Sharp injuries in Japanese operating theaters of HIV/AIDS referral hospitals 2009-2011. Ind Health. 2016;54:224-9.
PubMed
13) Association of periOperative Registered Nurses. Guideline for sharps safety. In:Guidelines for Perioperative Practice. Denver:AORN, Inc;2016. p. 417-40.
 
14) Centers for Disease Control and Prevention. Guideline for isolation precautions:preventing transmission of infectious agents in healthcare settings (2007). https://www.cdc.gov/infectioncontrol/guidelines/isolation/index.html
 
15) 国立感染症研究所. B型肝炎ワクチンの定期接種について. IASR. 2016;37:156-7.
 
16) Centers for Disease Control and Prevention. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States. Recommendations of the Advisory Committee on Immunization Practices (ACIP) PartII:immunization of adults. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5516a1.htm?s_cid=rr5516a1_e
 
17) Bruce MG, Bruden D, Hurlburt D, et al. Antibody levels and protection after hepatitis B vaccine:results of a 30-year follow-up study and response to a booster dose. J Infect Dis. 2016;214:16-22.
 
18) European Consensus Group on Hepatitis B Immunity. Are booster immunisations needed for lifelong hepatitis B immunity? Lancet. 2000;355:561-5.
 
19) Centers for Disease Control and Prevention. Workbook for designing, implementing and evaluating a sharps injury prevention program. https://www.cdc.gov/sharpssafety/pdf/sharpsworkbook_2008.pdf
 
20) U. S. Public Health Service. Updated U. S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR Recomm Rep. 2001;50:1-52.
PubMed
21) CDC. Testing and clinical management of health care personnel potentially exposed to hepatitis C virus-CDC guidance, United States, 2020. MMWR Recommend Rep. 2020;69:1-8.
PubMed
22) Kuhar DT, Henderson DK, Struble KA, et al. US Public Health Service Working Group. Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis. Infect Control Hosp Epidemiol. 2013;34:875-92.
 
23) Hewagama S, Krishnaswamy S, King L, et al. Human T-cell lymphotropic virus type 1 exposures following blood-borne virus incidents in central Australia, 2002-2012. Clin Infect Dis. 2014;59:85-7.
PubMed
24) 厚生労働省. HTLV-1 キャリア指導の手引. www.mhlw.go.jp/bunya/kenkou/kekkaku-kansenshou19/dl/htlv-1_d.pdf
 

4 医療関連感染予防のための水質管理

P.66 掲載の参考文献
1) CDC. Developing a water management program to reduce Legionella growth & spread in buildings. Version 1.1. https://www.cdc.gov/legionella/downloads/toolkit.pdf
 
2) Hayman DL. Legionellosis. Control of communicable diseases manual. 20th edition. Washington DC:American Public Health Association;2015. p. 334-7.
 
3) CNN. レジオネラ症の集団感染, 米ディズニーランドが冷却塔を閉鎖(2017. 11. 13). https://www.cnn.co.jp/usa/35110289.html
 
4) 時事ドットコムニュース. 加湿器でレジオネラ菌感染か=高齢者施設で男性死亡-大分(2018. 1. 19). https://www.jiji.com/jc/article?k=2018011901226&g=soc
 
5) 北海道新聞電子版. レジオネラ菌に感染 バス運転手2人入院 音更(2018. 1. 24). https://www.hokkaido-np.co.jp/article/158789
 
6) CDC. Legionella (Legionnaires' Disease and Pontiac Fever). Outbreaks. https://www.cdc.gov/legionella/outbreaks.html
PubMed
7) 厚生労働省. 建築物環境衛生管理基準について. 給水の管理. http://www.mhlw.go.jp/bunya/kenkou/seikatsu-eisei10/
 
8) 財団法人ビル管理教育センター発行, 厚生省生活衛生局企画課監修. 新版レジオネラ症防止指針(概要). 1999. http://www1.mhlw.go.jp/houdou/1111/h1126-2_13.html#no1-1
 
9) 建築物環境衛生維持管理要領等検討委員会. 建築物における維持管理マニュアル. 2008. http://www.mhlw.go.jp/bunya/kenkou/seikatsu-eisei09/03.html
 
10) CDC. Guidelines for environmental infection control in health-care facilities (2003). https://www.cdc.gov/infectioncontrol/pdf/guidelines/environmental-guidelines.pdf
 
11) Kanwar A, Cadnum JL, Xu D, et al. Hiding in plain sight:Contaminated ice machines are a potential source for dissemination of Gram-negative bacteria and Candida species in healthcare facilities. Infect Control Hosp Epidemiol. 2018;39:253-8.
PubMed
12) Kanwar A, Domitrovic TN, Koganti S, et al. A cold hard menace:A contaminated ice machine as a potential source for transmission of carbapenem-resistant Acinetobacter baumanii. Am J Infect Control. 2017;45:1273-5.
 
13) Furuhata K, Ishizaki N, Fukuyama M. Bacterial contamination in cold water samples obtained from water dispensers. Biocontrol Sci. 2015;20:147-51.
PubMed
14) Baumgartner A, Grand M. Bacteriological quality of drinking water from dispensers (coolers) and possible control measures. J Food Prot. 2006;69:3043-6.
 
15) 峰島三千男, 川西秀樹, 阿瀬智暢, 他. 日本透析医学会 2016年版 透析液水質基準. 透析会誌. 2016;49:697-725.
 
16) 公益社団法人日本臨床工学技士会 透析液等安全委員会. 透析液清浄化ガイドラインVer2.01. 2014. http://www.ja-ces.or.jp/ce/?p=2921
 

5 感染対策における管理図の活用

P.77 掲載の参考文献
1) 鐵健司, 編. 中村達男, 著. 新版 QC入門講座7 管理図の作り方と活用. 日本規格協会;2017.
 
2) Benneyan JC. Statistical quality control methods in infection control and hospital epidemiology, part I:introduction and basic theory. Infect Control Hosp Epidemiol. 1998;19:194-214.
 
3) Benneyan JC. Statistical quality control methods in infection control and hospital epidemiology, part II:chart use, statistical properties, and research issues. Infect Control Hosp Epidemiol. 1998;19:265-83.
 

6 微生物検査室におけるバイオセーフティ

P.91 掲載の参考文献
1) WHO. Laboratory biosafety manual 4th ed (2020). https://www.who.int/publications/i/item/9789240011311
 
2) Harding AL, Byers KB. Epidemiology of laboratory-associated infections. In:Biological safety. Washington DC, USA:ASM Press;2014. p. 53-77.
 
3) Mayhall CG. Nosocomial Infections in Diagnostic Laboratories. Epidemiology and prevention of nosocomial infections in healthcare workers. In:Hospital epidemiology and infection control 3rd ed. LW & W. p. 1431-41.
 
4) Singh K. Laboratory-acquired Infections. Clin Infect Dis. 2009;49:142-7.
PubMed
5) CDC. Biosafety in microbiological and biomedical laboratories 6th ed (2020).
 
6) WHO. Laboratory biosafety manual 3rd ed (2004). https://www.who.int/csr/resources/publications/biosafety/Biosafety7.pdf
 
7) Government of Canada. Pathogen Safety Data Sheets. https://www.canada.ca/en/public-health/services/laboratory-biosafety-biosecurity/pathogen-safety-data-sheetsrisk-assessment.html
 
8) The National Institute for Occupational Safety and Health (NIOSH). Hierarchy of controls. https://www.cdc.gov/niosh/topics/hierarchy/default.html
 
9) WHO. Tuberculosis laboratory biosafety manual (2012). https://www.who.int/publications/i/item/9789241504638
 
10) 日本結核病学会・日本臨床微生物学会・日本臨床衛生検査技師会. 結核菌検査に関するバイオセーフティマニュアル 第二版(2005). https://www.kekkaku.gr.jp/manual/manual.html
 

7 医療施設の建築・改築・解体工事における感染対策

P.102 掲載の参考文献
1) Hible L, editors. Infection prevention and control issues in the environment of care. Revised 3rd edition. Illinois:Joint Commission Resources;2017.
 
2) Weber DJ, Peppercorn A, Miller MB, et al. Preventing healthcare-associated Aspergillus infections:review of recent CDC/HICPAC recommendations. Med Mycol. 2009;47 Suppl 1:S199-209.
 
3) Vonberg RP, Gastmeier P. Nosocomial aspergillosis in outbreak settings. J Hosp Infect. 2006;63:246-54.
PubMed
4) Kanamori H, Weber DJ, Rutala WA. Healthcare outbreaks associated with a water reservoir and infection prevention strategies. Clin Infect Dis. 2016;62:1423-35.
PubMed
5) CDC. Legionnaires' disease and other infections associated with building water systems. https://www.cdc.gov/legionella/wmp/healthcare-facilities/healthcare-wmp-faq.html
 
6) 一般社団法人日本環境感染学会, 医療環境委員会. 医療環境リスク評価ツール集. http://www.kankyokansen.org/modules/iinkai/index.php?content_id=1
 
7) 日本医療福祉設備協会. 病院設備設計ガイドライン (空調設備編) HEAS-02-2022.
 
8) American Society for Healthcare Engineering. Infection control risk assessment matrix of precautions for construction & renovation. http://www.ashe.org/advocacy/organizations/CDC/pdfs/assessment_icra.pdf
 

8 感染源になりうる病院環境

P.110 掲載の参考文献
1) Otter JA, Yezli S, Salkeld JA, et al. Evidence that contaminated surfaces contribute to the transmission of hospital pathogens and an overview of strategies to address contaminated surfaces in hospital settings. Am J Infect Control. 2013;41(5 Suppl):S6-11.
 
2) Parkes LO, Hota SS. Sink-related outbreaks and mitigation strategies in healthcare facilities. Curr Infect Dis Rep. 2018;20:42.
PubMed
3) Jencson AL, Cadnum JL, Piedrahita C, et al. Hospital sinks are a potential nosocomial source of Candida infections. Clin Infect Dis. 2017;65:1954-5.
PubMed
4) Kanamori H, Weber DJ, Rutala WA. Healthcare outbreaks associated with a water reservoir and infection prevention strategies. Clin Infect Dis. 2016;62:1423-35.
PubMed
5) Hota S, Hirji Z, Stockton K, et al. Outbreak of multidrug-resistant Pseudomonas aeruginosa colonization and infection secondary to imperfect intensive care unit room design. Infect Control Hosp Epidemiol. 2009;30:25-33.
PubMed
6) Kotay S, Chai W, Guilford W, et al. Spread from the sink to the patient:In situ study using green fluorescent protein (GFP)-expressing Escherichia coli to model bacterial dispersion from hand-washing sink-trap reservoirs. Appl Environ Microbiol. 2017;83:e03327-16.
 
7) Hopman J, Tostmann A, Wertheim H, et al. Reduced rate of intensive care unit acquired Gram-negative bacilli after removal of sinks and introduction of 'water-free' patient care. Antimicrob Resist Infect Control. 2017;6:59.
PubMed
8) Shaw E, Gavalda L, Camara J, et al. Control of endemic multidrug-resistant Gram-negative bacteria after removal of sinks and implementing a new water-safe policy in an intensive care unit. J Hosp Infect. 2018;98:275-81.
 
9) Trillis F 3rd, Eckstein EC, Budavich R, et al. Contamination of hospital curtains with healthcare-associated pathogens. Infect Control Hosp Epidemiol. 2008;29:1074-6.
PubMed
10) Shek K, Patidar R, Kohja Z, et al. Rate of contamination of hospital privacy curtains on a burns and plastic surgery ward:a cross-sectional study. J Hosp Infect. 2017;96:54-8.
 
11) Woodard DR, Buttner M, Cruz P, et al. Microbial contamination of privacy curtains in the emergency department of a metropolitan hospital. J Hosp Infect. 2018;100:e153-4.
PubMed
12) Ohl M, Schweizer M, Graham M, et al. Hospital privacy curtains are frequently and rapidly contaminated with potentially pathogenic bacteria. Am J Infect Control. 2012;40:904-6.
PubMed
13) Shek K, Patidar R, Kohja Z, et al. Rate of contamination of hospital privacy curtains in a burns/plastic ward:a longitudinal study. Am J Infect Control. 2018;46:1019-21.
 
14) Larocque M, Carver S, Bertrand A, et al. Acquisition of bacteria on health care workers' hands after contact with patient privacy curtains. Am J Infect Control. 2016;44:1385-6.
PubMed
15) CDC. Guidelines for environmental infection control in health-care facilities. https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5210a1.htm
 
16) Friedman ND, Carmeli Y, Walton AL, et al. Carbapenem-resistant Enterobacteriaceae:a strategic roadmap for infection control. Infect Control Hosp Epidemiol. 2017;38:580-94.
PubMed
17) Ontario Agency for Health Protection and Promotion (Public Health Ontario), Provincial Infectious Disease Advisory Committee. Best practices for environmental cleaning for prevention and control of infections in all health care settings. 3rd edition. Toronto:Queen's Printer for Ontario;2018.
 
18) Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1999;20:250-78;quiz 279-80.
 
19) 平成17年2月1日付. 医政指発第0201004号. 厚生労働省医政局指導課長通知. 医療施設における院内感染の防止について. https://www.mhlw.go.jp/shingi/2006/09/dl/s0906-3d.pdf
 
20) Deshpande A, Cadnum JL, Fertelli D, et al. Are hospital floors an underappreciated reservoir for transmission of health care-associated pathogens? Am J Infect Control. 2017;45:336-8.
PubMed
21) Rashid T, VonVille HM, Hasan I, et al. Shoe soles as a potential vector for pathogen transmission:a systematic review. J Appl Microbiol. 2016;121:1223-31.
PubMed
22) Alam MJ, Anu A, Walk ST, et al. Investigation of potentially pathogenic Clostridium difficile contamination in household environs. Anaerobe. 2014;27:31-3.
PubMed
23) Janezic S, Mlakar S, Rupnik M. Dissemination of Clostridium difficile spores between environment and households:dog paws and shoes. Zoonoses Public Health. 2018;65:669-74.
PubMed
24) Rashid T, Vonville H, Hasan I, et al. Mechanisms for floor surfaces or environmental ground contamination to cause human infection:a systematic review. Epidemiol Infect. 2017;145:347-57.
PubMed
25) Buttner MP, Cruz-Perez P, Stetzenbach LD, et al. Measurement of airborne fungal spore dispersal from three types of flooring materials. Aerobiologia. 2002;18:1-11.
 
26) Anderson RL, Mackel DC, Stoler BS, et al. Carpeting in hospitals:an epidemiological evaluation. J Clin Microbiol. 1982;15:408-15.
PubMed
27) Skoutelis AT, Westenfelder GO, Beckerdite M, et al. Hospital carpeting and epidemiology of Clostridium difficile. Am J Infect Control. 1994;22:212-7.
PubMed
28) 高鳥浩介. 生活環境中の真菌とその生態. アレルギー. 2005;54:531-5.
Medical*Online
29) Gerson SL, Parker P, Jacobs MR, et al. Aspergillosis due to carpet contamination. Infect Control Hosp Epidemiol. 1994;15:221-3.
PubMed
30) PIDAC. Best practices for environmental cleaning for prevention and control of infections in all health care settings. 3rd edition. Toronto:Queen's Printer for Ontario;2018.
 
31) Weber DJ, Peppercorn A, Miller MB, et al. Preventing healthcare-associated Aspergillus infections:review of recent CDC/HICPAC recommendations. Med Mycol. 2009;47 Suppl 1:S199-209.
 
32) FEMA. Dealing with mold & mildew in your flood damaged home. https://www.fema.gov/pdf/rebuild/recover/fema_mold_brochure_english.pdf
 
33) Curtis L, Cali S, Conroy L, et al. Aspergillus surveillance project at a large tertiary-care hospital. J Hosp Infect. 2005;59:188-96.
 

9 清掃と医療関連感染

P.117 掲載の参考文献
1) Han JH, Sullivan N, Leas BF, et al. Cleaning hospital room surfaces to prevent health care-associated infections:a technical brief. Ann Intern Med. 2015;163:598-607.
PubMed
2) Rutala WA, Weber DJ. Selection of the ideal disinfectant. Infect Control Hosp Epidemiol. 2014;35:855-65.
PubMed
3) PIDAC. Best practices for environmental cleaning for prevention and control of infections in all health care settings. 3rd edition. Toronto:Queen's Printer for Ontario;2018.
 
4) CDC. Options for evaluating environmental cleaning. https://www.cdc.gov/hai/toolkits/appendices-evaluating-environ-cleaning.html
 
5) Hayden MK, Bonten MJ, Blom DW, et al. Reduction in acquisition of vancomycin-resistant Enterococcus after enforcement of routine environmental cleaning measures. Clin Infect Dis. 2006;42:1552-60.
PubMed
6) Datta R, Platt R, Yokoe DS, et al. Environmental cleaning intervention and risk of acquiring multidrug-resistant organisms from prior room occupants. Arch Intern Med. 2011;171:491-4.
PubMed
7) Marra AR, Schweizer ML, Edmond MB. No-touch disinfection methods to decrease multidrug-resistant organism infections:a systematic review and meta-analysis. Infect Control Hosp Epidemiol. 2018;39:20-31.
PubMed
8) Anderson DJ, Moehring RW, Weber DJ, et al. Effectiveness of targeted enhanced terminal room disinfection on hospital-wide acquisition and infection with multidrug-resistant organisms and Clostridium difficile:a secondary analysis of a multicentre cluster randomised controlled trial with crossover design (BETR Disinfection). Lancet Infect Dis. 2018;18:845-53.
PubMed
9) Diab-Elschahawi M, Assadian O, Blacky A, et al. Evaluation of the decontamination efficacy of new and reprocessed microfiber cleaning cloth compared with other commonly used cleaning cloths in the hospital. Am J Infect Control. 2010;38:289-92.
PubMed
10) Smith DL, Gillanders S, Holah JT, et al. Assessing the efficacy of different microfibre cloths at removing surface micro-organisms associated with healthcare-associated infections. J Hosp Infect. 2011;78:182-6.
PubMed

10 超音波プローブの消毒

P.124 掲載の参考文献
1) CDC. Guideline for disinfection and sterilization in healthcare facilities, 2008. https://www.cdc.gov/infectioncontrol/pdf/guidelines/disinfection-guidelines-H.pdf
 
2) Australasian College for Infection Prevention and Control (ACIPC) and Australasian Society for Ultrasound in Medicine (ASUM). Guidelines for reprocessing ultrasound transducers. https://onlinelibrary.wiley.com/doi/full/10.1002/ajum.12042
 
3) Abramowicz JS, Evans DH, Fowlkes JB, et al. Guidelines for cleaning transvaginal ultrasound transducers between patients. Ultrasound Med Biol. 2017;43:1076-9.
PubMed
4) Nyhsen CM, Humphreys H, Koerner RJ, et al. Infection prevention and control in ultrasound-best practice recommendations from the European Society of Radiology Ultrasound Working Group. Insights Imaging. 2017;8:523-35.
 
5) American Institute of Ultrasound in Medicine. Guidelines for cleaning and preparing external-and internal-use ultrasound transducers between patients, safe handling, and use of ultrasound coupling gel. https://www.aium.org/accreditation/Guidelines_Cleaning_Preparing.pdf
 
6) Rutala WA, Weber DJ. New developments in reprocessing semicritical items. Am J Infect Control. 2013;41:S60-6.
PubMed
7) 厚生労働省労働基準局. 医療機関におけるグルタルアルデヒドによる労働者の健康障害防止について(基発第0224007号). 2005.
 
8) 公益社団法人 全国労働基準関係団体連合会. 労働基準判例検索-全情報|日本海員掖済会(化学物質過敏症)事件. https://www.zenkiren.com/Portals/0/html/jinji/hannrei/shoshi/08532.html
 
9) Leroy S. Infectious risk of endovaginal and transrectal ultrasonography:systematic review and meta-analysis. J Hosp Infect. 2013;83:99-106.
PubMed
10) Lucet JC, Heard I, Roueli A, et al. Transvaginal ultrasound probes are HPV-free following low-level disinfection:a cross-sectional multicentre survey of 676 observations. Ultrasound Obstet Gynecol. 2019;54:688-95.
 
11) Gaillot O, Maruejouls C, Abachin E, et al. Nosocomial outbreak of Klebsiella pneumoniae producing SHV-5 extended-spectrum beta-lactamase, originating from a contaminated ultrasonography coupling gel. J Clin Microbiol. 1998;36:1357-60.
PubMed
12) Yamunadevi VR, Ramasubramanian V, Senthur Nambi P, et al. Outbreak of Burkholderia cepacia bacteraemia in a tertiary care centre due to contaminated ultrasound probe gel. J Hosp Infect. 2018;100:e257-8.
 
13) Cheng A, Sheng WH, Huang YC, et al. Prolonged postprocedural outbreak of Mycobacterium massiliense infections associated with ultrasound transmission gel. Clin Microbiol Infect. 2016;22:382. e1-382. e11.
 
14) Chittick P, Russo V, Sims M, et al. An outbreak of Pseudomonas aeruginosa respiratory tract infections associated with intrinsically contaminated ultrasound transmission gel. Infect Control Hosp Epidemiol. 2013;34:850-3.
PubMed
15) Shaban RZ, Maloney S, Gerrard J, et al. Outbreak of health care-associated Burkholderia cenocepacia bacteremia and infection attributed to contaminated sterile gel used for central line insertion under ultrasound guidance and other procedures. Am J Infect Control. 2017;45:954-8.
PubMed

11 手指衛生

P.145 掲載の参考文献
1) Sakihama T, Kayauchi N, Kamiya T, et al. Assessing sustainability of hand hygiene adherence 5 years after a contest-based intervention in 3 Japanese hospitals. Am J Infect Control. 2020;48:77-87.
PubMed
2) WHO. Evidence of hand hygiene to reduce transmission and infections by multidrug resistant organisms in health-care settings. https://www.who.int/gpsc/5may/MDRO_literature-review.pdf?ua=1
 
3) Boyce JM, Pittet D;Healthcare Infection Control Practices Advisory Committee;HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Guideline for hand hygiene in health-care settings. Recommendations of the healthcare infection control practices advisory committee and the hicpac/shea/apic/idsa hand hygiene task force. Society for healthcare epidemiology of America/association for professionals in Infection Control/Infectious Diseases Society of America. MMWR Recomm Rep. 2002;51:1-45, quiz CE1-4.
 
4) Centers for Disease Control and Prevention. Handwashing:Clean hands save lives. Show me the science-Why wash your hands? https://www.cdc.gov/handwashing/why-handwashing.html
 
5) SHEA/IDSA/APIC Practice Recommendation. Strategies to prevent healthcare-associated infections through hand hygiene:2022 Update. Infect Control Hosp Epidemiol. 2022;44:355-76.
PubMed
6) WHO. Hand hygiene posters. https://www.who.int/gpsc/5may/resources/posters/en/
 
7) Park, HY, Kim, SK, Lim, YJ, et al. Assessment of the appropriateness of hand surface coverage for health care workers according to World Health Organization hand hygiene guidelines. Am J Infect Control. 2014;42:559-61.
PubMed
8) Reilly JS, Price L, Lang S, et al. A pragmatic randomized controlled trial of 6-step vs 3-step hand hygiene technique in acute hospital care in the United Kingdom. Infect Control Hosp Epidemiol. 2016;37:661-6.
 
9) Pires D, Soule H, Bellissimo-Rodrigues F, et al. Hand hygiene with alcohol-based hand rub:how long is long enough? Infect Control Hosp Epidemiol. 2017;38:547-52.
 
10) Kirschner MH, Lang RA, Breuer B, et al. Transdermal resorption of an ethanol- and 2-propanol-containing skin disinfectant. Langenbecks Arch Surg. 2009;394:151-7.
PubMed
11) Kramer A, Below H, Bieber N, et al. Quantity of ethanol absorption after excessive hand disinfection using three commercially available hand rubs is minimal and below toxic levels for humans. BMC Infect Dis. 2007;7:117.
PubMed
12) WHO. My 5 moments for hand hygiene. https://www.who.int/infection-prevention/campaigns/clean-hands/5moments/en/
 
13) Provincial Infectious Diseases Advisory Committee. Best practices for hand hygiene in all health care settings, 4th edition. 2014. https://www.publichealthontario.ca/-/media/documents/bp-hand-hygiene.pdf?la=en
 
14) WHO Hand Hygiene Technical Reference Manual:手指衛生テクニカルリファレンスマニュアル(日本語訳). https://amr.ncgm.go.jp/pdf/Hand-hygiene-technical-reference_Japanese.pdf
 
15) WHO. A guide to the implementation of the WHO multimodal hand hygiene improvement strategy. https://www.who.int/gpsc/5may/Guide_to_Implementation.pdf
 
16) CDC. Guideline for hand hygiene in health-care settings. https://www.cdc.gov/mmwr/PDF/rr/rr5116.pdf
 
17) Stewardson A, Sax H, Longet-Di Pietro S, et al. Impact of observation and analysis methodology when reporting hand hygiene data. J Hosp Infect. 2011;77:358-9.
 
18) Yin J, Reisinger HS, Vander Weg M, et al. Establishing evidence-based criteria for directly observed hand hygiene compliance monitoring programs:a prospective, multicenter cohort study. Infect Control Hosp Epidemiol. 2014;35:1163-8.
PubMed
19) Boyce JM. Electronic monitoring in combination with direct observation as a means to significantly improve hand hygiene compliance. Am J Infect Control. 2017;45:528-35.
PubMed
20) Benudis A, Stone S, Sait AS, et al. Pitfalls and unexpected benefits of an electronic hand hygiene monitoring system. Am J Infect Control. 2019;47:1102-6.
PubMed
21) Steed C, Kelly JW, Blackhurst D, et al. Hospital hand hygiene opportunities:where and when (HOW2)? The how2 benchmark study. Am J Infect Control. 2011;39:19-26.
 
22) WHO. Hand hygiene monitoring and feedback. http://www.who.int/gpsc/5may/monitoring_feedback/en/
 
23) Zingg W, Holmes A, Dettenkofer M, et al. Hospital organisation, management, and structure for prevention of health-care-associated infection:a systematic review and expert consensus. Lancet Infect Dis. 2015;15:212-24.
PubMed
24) World Health Organization. WHO guidelines on hand hygiene in health care:first global patient safety challenge clean care is safe care. Geneva, Switzerland:World Health Organization, 2009. http://apps.who.int/iris/bitstream/handle/10665/44102/9789241597906_eng.pdf; sequence=1
 
25) Ontario Agency for Health Protection and Promotion (Public Health Ontario), Provincial Infectious Diseases Advisory Committee. Best practices for hand hygiene in all health care settings. 4th ed. Toronto, ON:Queen's Printer for Ontario;2014. https://www.publichealthontario.ca/-/media/documents/B/2014/bp-hand-hygiene.pdf?la=en
 
26) Bischoff WE, Reynolds TM, Sessler CN, et al. Handwashing compliance by health care workers:the impact of introducing an accessible, alcohol-based hand antiseptic. Arch Intern Med. 2000;160:1017-21.
PubMed
27) McCormick RD, Buchman TL, Maki DG. Double-blind, randomized trial of scheduled use of a novel barrier cream and an oil-containing lotion for protecting the hands of health care workers. Am J Infect Control. 2000;28:302-10.
 
28) Lastinger A, Gomez K, Manegold E, et al. Use of a patient empowerment tool for hand hygiene. Am J Infect Control. 2017;45:824-9.
PubMed
29) Storr J, Twyman A, Zingg W, et al. Core components for effective infection prevention and control programmes:new WHO evidence-based recommendations. Antimicrob Resist Infect Control. 2017;6:6.
PubMed

12 カテーテル関連尿路感染の予防

P.153 掲載の参考文献
1) European Centre for Disease Prevention and Control. Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals. Stockholm:ECDC;2013.
PubMed
2) Magill SS, O'Leary E, Janelle SJ, et al;Emerging Infections Program Hospital Prevalence Survey Team. Changes in prevalence of health care-associated infections in U. S. hospitals. N Engl J Med. 2018;379:1732-44.
PubMed
3) Garibaldi RA, Mooney BR, Epstein BJ, et al. An evaluation of daily bacteriologic monitoring to identify preventable episodes of catheter-associated urinary tract infection. Infect Control. 1982;3:466-70.
PubMed
4) Saint S, Lipsky BA, Goold SD. Indwelling urinary catheters:a one-point restraint? Ann Intern Med. 2002;137:125-7.
PubMed
5) Warren JW, Tenney JH, Hoopes JM, et al. A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J Infect Dis. 1982;146:719-23.
PubMed
6) Tambyah PA, Maki DG. Catheter-associated urinary tract infection is rarely symptomatic:a prospective study of 1,497 catheterized patients. Arch Intern Med. 2000;160:678.
PubMed
7) Saint S. Clinical and economic consequences of nosocomial catheter-related bacteriuria. Am J Infect Control. 2000;28:68.
PubMed
8) Leuck AM, Wright D, Ellingson L, et al. Complications of Foley catheters-is infection the greatest risk? J Urol. 2012;187:1662-6.
 
9) Agency for healthcare research and quality. Toolkit for reducing catheter-associated urinary tract infections in hospital units:implementation guide. Appendix K. Infographic Poster on CAUTI Prevention. https://www.ahrq.gov/hai/cauti-tools/impl-guide/implementationguide-appendix-k.html
 
10) Lo E, Nicolle LE, Coffin SE, et al. Strategies to prevent catheter-associated urinary tract infections in acute care hospitals:2014 update. Infect Control Hosp Epidemiol. 2014;35:464-79.
PubMed
11) Meddings J, Saint S, Fowler KE, et al. The Ann Arbor criteria for appropriate urinary catheter use in hospitalized medical patients:results obtained by using the RAND/UCLA appropriateness method. Ann Intern Med. 2015;162(9 Suppl):S1-34.
 
12) Agency for healthcare research and quality. Toolkit for reducing catheter-associated urinary tract infections in hospital units:implementation guide. Appendix E. Poster on Urinary Catheter Risks and Indications. https://www.ahrq.gov/professionals/quality-patientsafety/hais/cauti-tools/impl-guide/implementation-guide-appendix-e.html
 
13) Jain P, Parada JP, David A, et al. Overuse of the indwelling urinary tract catheter in hospitalized medical patients. Arch Intern Med. 1995;155:1425-9.
PubMed
14) Saint S, Wiese J, Amory JK, et al. Are physicians aware of which of their patients have indwelling urinary catheters? Am J Med. 2000;109:476-80.
PubMed
15) American Nurses Association. ANA CAUTI Prevention Tool. https://www.nursingworld.org/practice-policy/work-environment/health-safety/infection-prevention/ana-cauti-prevention-tool/
 

コラム 感染症業界ここがアカンやろ !

P.157 掲載の参考文献
1) Murphy DM, Hanchett M, Olmsted RN, et al. Competency in infection prevention:a conceptual approach to guide current and future practice. Am J Infect Control. 2012;40:296-303.
PubMed
2) European Centre for Disease Prevention and Control. Core competencies for infection control and hospital hygiene professionals in the European Union. https://www.ecdc.europa.eu/en/publications-data/core-competencies-infection-control-and-hospital-hygieneprofessionals-european
 

13 医療現場におけるマスクの使い方

P.166 掲載の参考文献
1) FDA. N95 respirators, surgical masks, face masks, and barrier face coverings. https://www.fda.gov/medical-devices/personal-protective-equipment-infection-control/n95-respirators-surgical-masks-face-masks-and-barrier-face-coverings
 
2) JHPIA/JSA. JIS T 9001:2021. 医療用マスク及び一般用マスクの性能要件及び試験方法.
 
3) ASTM International. ASTM Standards & COVID-19. https://www.astm.org/COVID-19/
 
4) 和田耕治, 吉川徹, 編著. 黒須一見, 長瀬仁, 著. 感染対策としての呼吸用防護具 フィットテストインストラクター陽性講座テキスト. フィットテスト研究会;2014.
 
5) 一般社団法人 職業感染制御研究会. 不良品マスクを見分ける方法について. http://jrgoicp.umin.ac.jp/index_ppewg_respirator_defective.html
 
6) 電動ファン付き呼吸用保護具の規格(平成26年11月28日 厚生労働省告示第455号). https://www.mhlw.go.jp/file/06-Seisakujouhou-11200000-Roudoukijunkyoku/0000068302.pdf
 
7) Radonovich LJ, Simberkoff MS, Bessesen MT, et al. N95 respirators vs medical masks for preventing influenza among health care personnel:a randomized clinical trial. JAMA. 2019;322:824-33.
PubMed
8) Long Y, Hu T, Liu L, et al. Effectiveness of N95 respirators versus surgical masks against influenza:a systematic review and meta-analysis. J Evid Based Med. 2020;13:93-101.
PubMed
9) Andrejko KL, Pry JM, Myers JF, et al. Effectiveness of face mask or respirator use in indoor public settings for prevention of SARS-CoV-2 infection-California, February-December 2021. MMWR Morb Mortal Wkly Rep. 2022;71:212-6.
PubMed
10) Collins AP, Service BC, Gupta S, et al. N95 respirator and surgical mask effectiveness against respiratory viral illnesses in the healthcare setting:a systematic review and meta-analysis. J Am Coll Emerg Physicians Open. 2021;2:e12582.
 
11) Kim MS, Seong D, Li H, et al. Comparative effectiveness of N95, surgical or medical, and non-medical facemasks in protection against respiratory virus infection:a systematic review and network meta-analysis. Rev Med Virol. 2022;32:e2336.
PubMed
12) Loeb M, Bartholomew A, Hashmi M, et al. Medical masks versus N95 respirators for preventing COVID-19 among health care workers. Ann Intern Med. 2022;175:1629-38.
PubMed
13) WHO. Infection prevention and control during health care when coronavirus disease (COVID-19) is suspected or confirmed. Interim guidance, 12 July 2021. https://www.who.int/publications/i/item/WHO-2019-nCoV-IPC-2021.1
 
14) CDC. Interim infection prevention and control recommendations for healthcare personnel during the coronavirus disease 2019 (COVID-19) pandemic, Updated Sept. 23, 2022. https://www.cdc.gov/coronavirus/2019-ncov/hcp/infection-control-recommendations.html
 
15) CDC. Isolation precautions. https://www.cdc.gov/infectioncontrol/guidelines/isolation/index.html
 

14 新興感染症のパンデミックにおける職業感染予防

P.175 掲載の参考文献
1) WHO. Occupational health and safety for health workers in the context of COVID-19. https://openwho.org/courses/COVID-19-occupational-health-and-safety
 
2) WHO. Coronavirus disease (COVID-19) outbreak:rights, roles and responsibilities of health workers, including key considerations for occupational safety and health. https://www.who.int/publications/i/item/coronavirus-disease-(covid-19)-outbreak-rights-roles-and-responsibilities-of-health-workers-including-key-considerations-for-occupationalsafety-and-health
 
3) OSHA. Guidance on preparing workplaces for COVID-19. https://www.osha.gov/Publications/OSHA3990.pdf
 
4) NIOSH. Hierarchy of controls. https://www.cdc.gov/niosh/topics/hierarchy/default.htm
 

15 日常と非日常をつなぐ医療関連感染予防・制御の体制

P.185 掲載の参考文献
1) WHO. Guidelines on core components of infection prevention and control programmes at the national and acute health care facility level. https://www.who.int/publications/i/item/9789241549929
 
2) WHO. Minimum requirements for infection prevention and control programmes. https://www.who.int/publications/i/item/9789241516945
 
3) Billings C, Bernard H, Caffery L, et al. Advancing the profession:an updated future-oriented competency model for professional development in infection prevention and control. Am J Infect Control. 2019;47:602-14.
PubMed
4) CDC. Guideline for isolation precautions:preventing transmission of infectious agents in healthcare settings (2007). https://www.cdc.gov/infectioncontrol/guidelines/isolation/appendix/standard-precautions.html
 
5) ニザム・ダマーニ, 著. 岩田健太郎, 監修. 感染予防, そしてコントロールのマニュアル第2版. メディカル・サイエンス・インターナショナル;2020.
 
6) Ontario Agency for Health Protection and Promotion (Public Health Ontario), Provincial Infectious Diseases Advisory Committee. Best Practices for Hand Hygiene in All Health Care Settings. 4th ed. Toronto, ON:Queen's Printer for Ontario;2014.
 
7) WHO. WHO multimodal improvement strategy. https://www.who.int/infection-prevention/publications/ipc-cc-mis.pdf
 

書評

最近チェックした商品履歴

Loading...